Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease

Brain

Volumn 136, Issue 7, 2013, Pages 2159-2172

  Fisher, Simon P ^a   Black, Sarah W ^a   Schwartz, Michael D ^a   Wilk, Alan J ^a   Chen, Tsui Ming ^a   Lincoln, Webster U ^a   Liu, Helen W ^a   Kilduff, Thomas S ^a   Morairty, Stephen R ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

biomarkers; EEG; Huntington's disease; R6 2 transgenic mice; sleep

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORE TEMPERATURE; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; GENOTYPE; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; NONREM SLEEP; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REM SLEEP; SENSITIVITY ANALYSIS; SLEEP; SLEEP TIME; SLEEP WAKING CYCLE; TELEMETRY; THETA RHYTHM; WILD TYPE;

EID: 84879926757     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt132     Document Type: Article

References (61)

1. Arnulf I, Nielsen J, Lohmann E, Schiefer J, Schieffer J, Wild E, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol 2008; 65: 482-8
2. Aziz NA, Anguelova GV, Marinus J, Lammers GJ, Roos RA. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord 2010; 16: 345-50
3. Björkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med 2008; 205: 1869-77
4. Bode FJ, Stephan M, Wiehager S, Nguyen HP, Björkqvist M, Von Hörsten S, et al. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model. Behav Brain Res 2009; 205: 175-82
5. Borbély AA. A two process model of sleep regulation. Hum Neurobiol 1982; 1: 195-204
6. Bracci E, Centonze D, Bernardi G, Calabresi P. Voltage-Dependent membrane potential oscillations of rat striatal fast-spiking interneurons. J Physiol 2003; 549: 121-30
7. Bragin A, Jandó G, Ná dasdy Z, Hetke J, Wise K, Buzsá ki G. Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat. J Neurosci 1995; 15: 47-60
8. Bylsma FW, Peyser CE, Folstein SE, Folstein MF, Ross C, Brandt J. EEG power spectra in Huntington's disease: Clinical and neuropsychological correlates. Neuropsychologia 1994; 32: 137-50
9. Canolty RT, Edwards E, Dalal SS, Soltani M, Nagarajan SS, Kirsch HE, et al. High gamma power is phase-locked to theta oscillations in human neocortex. Science 2006; 313: 1626-8
10. Cayzac S, Delcasso S, Paz V, Jeantet Y, Cho YH. Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease. Proc Natl Acad Sci USA 2011; 108: 9280-5
11. Cepeda C, Cummings DM, AndréVM, Holley SM, Levine MS. Genetic mouse models of Huntington's disease: Focus on electrophysiological mechanisms. ASN Neuro 2010; 2: E00033
12. Cepeda C, Wu N, AndréVM, Cummings DM, Levine MS. The corticostriatal pathway in Huntington's disease. Prog Neurobiol 2007; 81: 253-71
13. Cummings DM, AndréVM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, et al. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci 2009; 29: 10371-86
14. Cuturic M, Abramson RK, Vallini D, Frank EM, Shamsnia M. Sleep patterns in patients with Huntington's disease and their unaffected first-Degree relatives: A brief report. Behav Sleep Med 2009; 7: 245-54
15. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90: 537-48
16. Deboer T, Tobler I. Temperature dependence of EEG frequencies during natural hypothermia. Brain Res 1995; 670: 153-6
17. Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR. Mouse models of Huntington disease: Variations on a theme. Dis Model Mech 2009; 2: 123-9
18. Estrada-Sá nchez AM, Montiel T, Segovia J, Massieu L. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-Dependent and correlates with decreased levels of glutamate transporters. Neurobiol Dis 2009; 34: 78-86
19. Fain JN, Del Mar NA, Meade CA, Reiner A, Goldowitz D. Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation. Hum Mol Genet 2001; 10: 145-52
20. Franken P, Dijk DJ, Tobler I, Borbély AA. Sleep deprivation in rats: Effects on EEG power spectra, vigilance states, and cortical temperature. Am J Physiol 1991; 261: R198-208
21. Franken P, Dijk DJ, Tobler I, Borbély AA. High-frequency components of the rat electrocorticogram are modulated by the vigilance states. Neurosci Lett 1994; 167: 89-92.
22. Georgiou-Karistianis N, Gray MA, Domínguez DJF, Dymowski AR, Bohanna I, Johnston LA, et al. Automated differentiation of pre-Diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: The IMAGE-HD study. Neurobiol Dis 2013; 51: 82-92
23. Gil JM, Rego AC. The R6 lines of transgenic mice: A model for screening new therapies for Huntington's disease. Brain Res Rev 2009; 59: 410-31
24. Goodman AO, Murgatroyd PR, Medina-Gomez G, Wood NI, Finer N, Vidal-Puig AJ, et al. The metabolic profile of early Huntington's disease-A combined human and transgenic mouse study. Exp Neurol 2008; 210: 691-8
25. Goodman AO, Rogers L, Pilsworth S, McAllister CJ, Shneerson JM, Morton AJ, et al. Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease. Curr Neurol Neurosci Rep 2011; 11: 211-7.
26. Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL. Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease. J Neurosci 2007; 27: 8989-98
27. Hong SL, Cossyleon D, Hussain WA, Walker LJ, Barton SJ, Rebec GV. Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's disease. PloS One 2012; 7: E47026
28. Hunter A, Bordelon Y, Cook I, Leuchter A. QEEG Measures in Huntington's disease: A pilot study. PLoS Curr 2010; 2: RRN1192
29. Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, et al. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol 2001; 86: 2667-77
30. Kudo T, Schroeder A, Loh DH, Kuljis D, Jordan MC, Roos KP, et al. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Exp Neurol 2011; 228: 80-90
31. Li JY, Popovic N, Brundin P. The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx 2005; 2: 447-64
32. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506
33. Maywood ES, Fraenkel E, McAllister CJ, Wood N, Reddy AB, Hastings MH, et al. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J Neurosci 2010; 30: 10199-204
34. Miller BR, Walker AG, Barton SJ, Rebec GV. Dysregulated neuronal activity patterns implicate corticostriatal circuit dysfunction in multiple rodent models of Huntington's disease. Front Syst Neurosci 2011; 5: 26
35. Miller BR, Walker AG, Shah AS, Barton SJ, Rebec GV. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J Neurophysiol 2008; 100: 2205-16
36. Morton AJ, Glynn D, Leavens W, Zheng Z, Faull RL, Skepper JN, et al. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice. Neurobiol Dis 2009; 33: 331-41
37. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci 2005; 25: 157-63
38. Nguyen L, Bradshaw JL, Stout JC, Croft RJ, Georgiou-Karistianis N. Electrophysiological measures as potential biomarkers in Huntington's disease: Review and future directions. Brain Res Rev 2010; 64: 177-94
39. Oakeshott S, Balci F, Filippov I, Murphy C, Port R, Connor D, et al. Circadian abnormalities in motor activity in a BAC transgenic mouse model of Huntington's disease. PLoS Curr 2011; 3: RRN1225
40. Painold A, Anderer P, Holl AK, Letmaier M, Saletu-Zyhlarz GM, Saletu B, et al. EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease. J Neurol 2011; 258: 840-54
41. Pallier PN, Maywood ES, Zheng Z, Chesham JE, Inyushkin AN, Dyball R, et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J Neurosci 2007; 27: 7869-78
42. Pallier PN, Morton AJ. Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease. Brain Res 2009; 1279: 90-8
43. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, et al. Detection of Huntington's disease decades before diagnosis: The Predict-HD study. J Neurol Neurosurg Psychiatry 2008; 79: 874-80
44. Petersén A, Gil J, Maat-Schieman ML, Björkqvist M, Tanila H, Araú jo IM, et al. Orexin loss in Huntington's disease. Hum Mol Genet 2005; 14: 39-47
45. Pignatelli M, Lebreton F, Cho YH, Leinekugel X. "Ectopic" theta oscillations and interictal activity during slow-wave state in the R6/1 mouse model of Huntington's disease. Neurobiol Dis 2012; 48: 409-17
46. Pokrovskaia ZA, Insarova NG. The EEG characteristics of patients with Huntington's chorea and their clinically healthy relatives. Zh Nevropatol Psikhiatr Im SS Korsakova 1988; 88: 22-6
47. Rebec G V, Conroy SK, Barton SJ. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: Variations with behavioral state and repeated ascorbate treatment. Neuroscience 2006; 137: 327-36
48. Rosas HD, Salat DH, Lee SY, Zaleta AK, Hevelone N, Hersch SM. Complexity and heterogeneity: What drives the ever-changing brain in Huntington's disease? Ann N Y Acad Sci 2008; 1147: 196-205
49. Scott DF, Heathfield KW, Toone B, Margerison JH. The EEG in Huntington's chorea: A clinical and neuropathological study. J Neurol Neurosurg Psychiatry 1972; 35: 97-102
50. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971-83
51. Tort AB, Komorowski RW, Manns JR, Kopell NJ, Eichenbaum H. Thetagamma coupling increases during the learning of item-context associations. Proc Natl Acad Sci USA 2009; 106: 20942-7
52. Van der Burg JM, Bacos K, Wood NI, Lindqvist A, Wierup N, Woodman B, et al. Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 2008; 29: 41-51
53. Van Wamelen DJ, Aziz NA, Anink JJ, Van Steenhoven R, Angeloni D, Fraschini F, et al. Suprachiasmatic nucleus neuropeptide expression in Huntington's disease patients. Sleep 2013; 36: 117-25
54. Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998; 57: 369-84
55. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559-77
56. Walker AG, Miller BR, Fritsch JN, Barton SJ, Rebec GV. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J Neurosci 2008; 28: 8973-82
57. Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 2006; 4: 349-62
58. Whittington MA, Traub RD, Jefferys JG. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 1995; 373: 612-5
59. Wiegand M, Möller AA, Lauer CJ, Stolz S, Schreiber W, Dose M, et al. Nocturnal sleep in Huntington's disease. J Neurol 1991; 238: 203-8
60. Williams RH, Morton AJ, Burdakov D. Paradoxical function of orexin/ ypocretin circuits in a mouse model of Huntington's disease. Neurobio Dis 2011; 42: 438-45
61. Zimbelman JL, Paulsen JS, Mikos A, Reynolds NC, Hoffmann RG, Rao SM. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc 2007; 13: 758-69